These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 30809021)
1. Metformin and glucose starvation decrease the migratory ability of hepatocellular carcinoma cells: targeting AMPK activation to control migration. Ferretti AC; Hidalgo F; Tonucci FM; Almada E; Pariani A; Larocca MC; Favre C Sci Rep; 2019 Feb; 9(1):2815. PubMed ID: 30809021 [TBL] [Abstract][Full Text] [Related]
2. AMPK and PKA interaction in the regulation of survival of liver cancer cells subjected to glucose starvation. Ferretti AC; Tonucci FM; Hidalgo F; Almada E; Larocca MC; Favre C Oncotarget; 2016 Apr; 7(14):17815-28. PubMed ID: 26894973 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma. Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093 [TBL] [Abstract][Full Text] [Related]
4. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients. Abdelmonsif DA; Sultan AS; El-Hadidy WF; Abdallah DM Mol Diagn Ther; 2018 Feb; 22(1):115-127. PubMed ID: 29094287 [TBL] [Abstract][Full Text] [Related]
5. Alpha lipoic acid diminishes migration and invasion in hepatocellular carcinoma cells through an AMPK-p53 axis. Hidalgo F; Ferretti AC; Etichetti CB; Baffo E; Pariani AP; Maknis TR; Bussi J; Girardini JE; Larocca MC; Favre C Sci Rep; 2024 Sep; 14(1):21275. PubMed ID: 39261583 [TBL] [Abstract][Full Text] [Related]
6. PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27 Tuo L; Xiang J; Pan X; Hu J; Tang H; Liang L; Xia J; Hu Y; Zhang W; Huang A; Wang K; Tang N J Exp Clin Cancer Res; 2019 Feb; 38(1):50. PubMed ID: 30717766 [TBL] [Abstract][Full Text] [Related]
7. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression. Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054 [TBL] [Abstract][Full Text] [Related]
8. Negative regulation of Sirtuin 1 by AMP-activated protein kinase promotes metformin-induced senescence in hepatocellular carcinoma xenografts. Zhou X; Chen J; Chen L; Feng X; Liu Z; Hu L; Zeng Z; Jia X; Liang M; Shi B; Yi G; Liu J Cancer Lett; 2017 Dec; 411():1-11. PubMed ID: 28964787 [TBL] [Abstract][Full Text] [Related]
9. Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway. Zhao C; Zheng L; Ma Y; Zhang Y; Yue C; Gu F; Niu G; Chen Y Int J Immunopathol Pharmacol; 2024; 38():3946320241249445. PubMed ID: 38679570 [TBL] [Abstract][Full Text] [Related]
10. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK. Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902 [TBL] [Abstract][Full Text] [Related]
11. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells. Kim YW; Jang EJ; Kim CH; Lee JH Chem Biol Interact; 2017 Jan; 261():108-117. PubMed ID: 27871897 [TBL] [Abstract][Full Text] [Related]
12. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells. Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855 [TBL] [Abstract][Full Text] [Related]
13. SOX18 Affects Cell Viability, Migration, Invasiveness, and Apoptosis in Hepatocellular Carcinoma (HCC) Cells by Participating in Epithelial-to-Mesenchymal Transition (EMT) Progression and Adenosine Monophosphate Activated Protein Kinase (AMPK)/Mammalian Target of Rapamycin (mTOR). Sun Y; Lei B; Huang Q Med Sci Monit; 2019 Aug; 25():6244-6254. PubMed ID: 31427562 [TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase suppresses the in vitro and in vivo proliferation of hepatocellular carcinoma. Cheng J; Huang T; Li Y; Guo Y; Zhu Y; Wang Q; Tan X; Chen W; Zhang Y; Cheng W; Yamamoto T; Jing X; Huang J PLoS One; 2014; 9(4):e93256. PubMed ID: 24709998 [TBL] [Abstract][Full Text] [Related]
16. Metformin exerts anti-tumor effects via Sonic hedgehog signaling pathway by targeting AMPK in HepG2 cells. Hu A; Hu Z; Ye J; Liu Y; Lai Z; Zhang M; Ji W; Huang L; Zou H; Chen B; Zhong J Biochem Cell Biol; 2022 Apr; 100(2):142-151. PubMed ID: 34990285 [TBL] [Abstract][Full Text] [Related]
17. Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma. Zhou X; Chen J; Yi G; Deng M; Liu H; Liang M; Shi B; Fu X; Chen Y; Chen L; He Z; Wang J; Liu J Oncotarget; 2016 Jan; 7(1):873-84. PubMed ID: 26621849 [TBL] [Abstract][Full Text] [Related]
18. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming. Chen H; Wu D; Bao L; Yin T; Lei D; Yu J; Tong X Biomed Pharmacother; 2019 Mar; 111():1353-1358. PubMed ID: 30841449 [TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits angiogenesis induced by interaction of hepatocellular carcinoma with hepatic stellate cells. Qu H; Yang X Cell Biochem Biophys; 2015 Mar; 71(2):931-6. PubMed ID: 25326336 [TBL] [Abstract][Full Text] [Related]